This article was originally published in The Gray Sheet
Executive SummaryA story in the Aug. 27 issue erroneously referred to a patent reform bill (H.R. 1908) as "House-approved" (1"The Gray Sheet" Aug. 27, 2007, p. 3). The bill cleared the House Judiciary Committee, but has not yet been put to a vote on the House floor...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.